PAIGE KIGHT: Open Payments
NPI 1538661269 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 10 payments from 7 companies in 2025. Trend: 2023 $406 · 2024 $159 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $82 |
| Dexcom, Inc. | 1 | $55 |
| Lilly USA, LLC | 2 | $32 |
| Corcept Therapeutics | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Ascensia Diabetes Care Us Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Ozempic, Dexcom G6 Transmitter, Korlym, NEXLETOL, MOUNJARO, JARDIANCE, BREZTRI.
Industry payments across SC — which companies pay providers there.
